Abstract: The present invention is concerned with a kit containing a plurality of hormone units for use in a contraceptive method which consists of two alternating consecutive phases, sometimes referred to as a sequential method or sequential regimen.

Abstract: The present invention relates to a contraceptive method comprising the administration of a hormone composition in an amount effective to inhibit ovulation. More specifically the invention relates to the use of a hormone composition in the manufacture of a kit containing a plurality of dosage units for use in a contraceptive method, which method comprises administering a sequence of said dosage units to a female of childbearing capability so as to provide the hormone composition in an amount which is effective to inhibit ovulation, wherein the hormone composition is dydrogesterone component or a combination of estrogen and dydrogesterone component.

Abstract: One aspect of the invention is concerned with a method of hormone replacement therapy, which method comprises administering to a person in need of such a therapy an effective amount of an estrogenic component selected from the group consisting of: substances represented by the formula (I) in which formula R1, R2, R3, R4 independently are a hydrogen atom, a hydroxyl group or an alokxy group with 1-5 carbon atoms; each of R5, R6, R7 is a hydroxyl group; and no more than 3 of R1, R2, R3, R4 are hydrogen atoms; precursors capable of liberating a substance according to the aforementioned formula when used in the present method; and mixtures thereof; said composition containing virtually no progestogen or anti-progestin. Another aspect of the invention relates to a drug delivery system for enteral or parenteral administration that contains at least 1 &mgr;g of the aforementioned estrogenic component and virtually no progestogen or anti-progestin.

Abstract: The present invention is concerned with a kit containing a plurality of hormone units for use in a contraceptive method which consists of three alternating consecutive phases, sometimes referred to as a sequential method or sequential regimen.

Abstract: A method of contraception in mammalian females, which method comprises the parenteral or rectal administration of an estrogenic component and a progestogenic component to a female of childbearing capability in an amount effective to inhibit ovulation, wherein the estrogenic component is selected from the group consisting of substances represented by the following formula (1) 1

Abstract: Disclosed is a method of increasing libido in a woman, said method comprising administering to said woman an effective amount of an estrogenic component selected from the group consisting of: substances represented by the following formula (I) in which formula R1, R2, R3, R4 independently are a hydrogen atom, a hydroxyl group or an alkoxy group with 1-5 carbon atoms; each of R5, R6, R7 is a hydroxyl group; no more than 3 of R1, R2, R3, R4 are hydrogen atoms; precursors capable of liberating a substance according to the aforementioned formula when used in the present method; and mixtures of one or more of the aforementioned substances and/or precursors.

Abstract: A compact disc playable on an audio CD player has been provided with non-PCM encoded information. The non-PCM information is arranged in blocks of one or more most significant bits (MSBs). At least one MSB of each block is used for PCM encoding of a low-frequency signal, preferably in the frequency band below 2 kHz. The at least one MSB is used for encoding sound that has been written onto the compact disc as non-PCM encoded information.

Abstract: The present invention relates to a method to prevent a premature LH surge. The method employs the administration of the gonadotropin releasing hormone antagonist ganirelix in an amount between 0.125-1 mg in combination with exogenous FSH. The method can be used in the treatment of women undergoing controlled ovarian superovulation.

Abstract: An estrogen-free contraceptive is provided which does not have the bleeding-related drawbacks of conventional progestogen-only pills. Thus the invention is a contraceptive kit comprising a combined means for the simultaneous daily administration of a progestogen as the sole contraceptively effective ingredient and an anti-progestogen. Said combined means preferably is in the form of tablets having a normal contraceptive dose of the progestogen and low dose of the anti-progestogen.

Abstract: An estrogen-free contraceptive is disclosed which does not have the bleeding-related drawbacks of conventional progestogen-only pills. The invention includes a contraceptive kit comprising a combined means for the simultaneous daily administration of a progestogen and an anti-progestogen. The combined means may be in the form of tablets having a normal contraceptive dose of the progestogen and a low dose of the anti-progestogen.

Abstract: The present invention relates to a method to prevent a premature LH surge. The method employs the administration of the gonadotropin releasing hormone antagonist ganirelix in an amount dependent on the body weight of the patient. The method can be used in combination with administration of exogenous FSH in the treatment of women undergoing controlled ovarian super-ovulation.

Abstract: A contraceptive and/or HRT (hormone replacement therapy) kit comprising sequential daily dosage units each containing as the sole contraceptively effective ingredient a progestogen, or as the effective ingredient for HRT a progestogen with or without an estrogen or an estrogen only, and further two or more dosage units comprising an anti-progestogen. The present invention also provides contraceptive and HRT methods comprising administering daily dosage units of a progestogen and anti-progestogen.

Abstract: A contraceptive and/or HRT (hormone replacement therapy) kit comprising sequential daily dosage units each containing as the sole contraceptively effective ingredient a progestogen, or as the effective ingredient for HRT a progestogen with or without an estrogen or an estrogen only, and further two or more dosage units comprising an anti-progestogen. The present invention also provides contraceptive and HRT methods comprising administering daily dosage units of a progestogen and anti-progestogen.

Abstract: The present invention is concerned with a kit containing a plurality of hormone units for use in a contraceptive method which consists of two alternating consecutive phases, sometimes referred to as a sequential method or sequential regimen.

Abstract: A contraceptive method comprises the administration of a hormone composition in an amount effective to inhibit ovulation. More specifically the invention relates to the use of a hormone composition in the manufacture of a kit containing a plurality of dosage units for use in a contraceptive method, which method comprises administering a sequence of the dosage units to a female of childbearing capability so as to provide the hormone composition in an amount which is effective to inhibit ovulation, wherein the hormone composition is dydrogesterone component or a combination of estrogen and dydrogesterone component.

Abstract: A compact disc playable on an audio CD player has been provided with non-PCM encoded information. The non-PCM information is arranged in blocks of one or more most significant bits (MSBs). At least one MSB of each block is used for PCM encoding of a low-frequency signal, preferably in the frequency band below 2 kHz. The at least one MSB is used for encoding sound that has been written onto the compact disc as non-PCM encoded information.

Abstract: A method of receiving teletext pages is disclosed. The receiver creates a table of flags indicating for each page whether said page is either available or not available in the transmission. In order to register the absence of pages which are no longer transmitted, two tables (460, 461) are alternately used. While one table is created, the other one is read to provide the presence or absence of information. The creation of a table is deemed completed after a given number of pages has been received more than once.

Abstract: Disclosed is a contraceptive and/or HRT (hormone replacement therapy) kit comprising sequential daily dosage units each containing as the sole contraceptively effective ingredient of a progestogen, or as effective ingredient for HRT a progestogen with or without an estrogen or an estrogen only, and further two or more dosage units comprising an anti-progestogen. One of the anti-progestogen is administered at the beginning and the others regularly divided throughout the cycle, preferably one only in the middle of the cycle.

Abstract: The invention relates to a method of displaying a multi-level menu. A first menu level is displayed in a first display area, while, in response to selection of a menu item of the first menu level, a second menu level is displayed in a second display area having a fixed position relative to the first display area, irrespective of the position of the selected menu item of the first menu level. Further menu levels may be displayed in further display areas having a fixed position with respect to the other display areas. Selected items of different menu levels may be visually connected.

Abstract: The invention relates to a method of rating database objects, such as broadcast programs in an EPG database. The objects are categorized in accordance with a multi-level category scheme with a first level of categories and a second level of categories subordinate to a respective category of the first level. The rating of a category of the first level is computed as a function , for example the average, of ratings of subordinate categories of the second level. Ratings are visually represented as different colors or different degrees of saturation of the same color.